Dana-Farber Research News 04.15.2026 - Summary - MDSpire
From the Journals
Feature

Dana-Farber Research News 04.15.2026

This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from March 16 - 31.

  • April 15, 2026

  • 22 min

Share

Dana-Farber's Research News highlights significant contributions from its faculty, with publications from March 16-31, 2026. Key research includes the Tumor-Associated Photoreceptor Signature linking various central nervous system malignancies, ethical considerations in monetary transfer interventions for cancer research, and novel treatment strategies for androgen deprivation therapy-related vasomotor symptoms. The newsletter serves as an important resource for updates in cancer research and the evolving landscape of clinical therapies.

Original Source(s)

Dana-Farber Research News 04.15.2026

  • April 15, 2026

Related Content

Is Standard of Care Optimal for the Individual Patient?

I am writing this from the hospital waiting room. My father is undergoing an 11-hour surgery to remove his parotid gland and a squamous cell carcinoma that has metastasized from his cheek and invaded ...

LuPSMA-617 and Pembrolizumab in mCRPC

In an Australian phase IB to II study (PRINCE) reported in The Lancet Oncology, Sandhu et al found that the combination of lutetium-177–labeled PSMA-617 (LuPSMA-617) and pembrolizumab was active in pa...

From Spectra to Structure: An Interview with Novogaia’s Tess Bevers

Novogaia’s transformer-based model converts untargeted mass spectra into structural predictions for early-stage drug discovery